Establishment of hybrid cell lines producing monoclonal antibodies to a synthetic peptide from the E1 region of the hepatitis C virus

Journal of Immunoassay and Immunochemistry

Volumn 29, Issue 1, 2008, Pages 91-104

  Tabll, Ashraf A ^a   Khalil, Samy B ^b   El Shenawy, Reem M ^a   Esmat, Gamal ^c   Helmy, Amr ^d   Attallah, Abdel Fattah ^e   El Awady, Mostafa K ^a  

^a NATIONAL RESEARCH CENTRE   (Egypt)

^b US Naval Medical Research Unit No 3 Egypt   (Egypt)

^c CAIRO UNIVERSITY   (Egypt)

^d MENOUFIA UNIVERSITY   (Egypt)

^e Biotechnology Research Center   (Egypt)

Author keywords

Antigen; Diagnosis; Envelope 1; Hepatitis C virus; Hybridoma; Monoclonal antibody

Indexed keywords

GLYCOPROTEIN E1; GLYCYLHISTIDYLARGINYLMETHIONYLALANYLTRYPTOPHYLASPARTYLMETHIONYLMETHIONINE; IMMUNOGLOBULIN G1; MONOCLONAL ANTIBODY; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCING CELL; ANTIGEN DETECTION; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; HYBRID CELL; IMMUNIZATION; MAJOR CLINICAL STUDY; MOUSE; MYELOMA CELL; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN DOMAIN; SCHOOL CHILD; SPLEEN CELL; WESTERN BLOTTING;

ADOLESCENT; ADULT; ANIMALS; ANTIBODIES, MONOCLONAL; BLOTTING, WESTERN; CELL LINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS C; HEPATITIS C ANTIGENS; HUMANS; HYBRIDOMAS; MALE; MICE; MICE, INBRED BALB C; MIDDLE AGED; PEPTIDES; SEROLOGIC TESTS; VIRAL ENVELOPE PROTEINS;

EID: 37249027759     PISSN: 15321819     EISSN: 15324230     Source Type: Journal    
DOI: 10.1080/15321810701735161     Document Type: Article

References (25)

1. Chen, S.; Morgan, T. The natural history of hepatitis C virus (HCV) infection. Int. J. Med. Sci. 2006, 3, 47-52.
2. Mohamed, M.; Bakr, I.; El-Hoseiny, M.; Arafa, N.; Hassan, A.; Ismail, S.; Anwar, M.; Attala, M.; Rekacewicz, C.; Zalata, K.; Abdel-Hamid, M.; Esmat, G.; Fontanet, A. HCV-related morbidity in a rural community of. Egypt. J. Med. Virol. 2006, 78 (9), 1185-1189.
3. Talaat, M.; Kandeel, A.; Rasslan, O.; Hajjeh, R.; Hallaj, Z.; El-Sayed, N.; Mahoney, F. Evolution of infection control in Egypt: achievements and challenges. Am. J. Infect. Contr. 2006, 34 (4), 193-200.
4. Strickland, G. Liver disease in Egypt: hepatitis C superseded schistosomiasis as a result of latrogenic and biological factors. Hepatology 2006, 43 (5), 915-922.
5. Abdel-Hamid, M.; El-Daly, M.; Molnegren, V.; El-Kafrawy, S.; Abdel-Latif, S.; Esmat, G.; Strickland, G.; Loffredo, C.; Albert, J.; Widell, A. Genetic diversity in hepatitis C virus in Egypt and possible association with hepatocellular carcinoma. J. Gen. Virol. 2007, 88 (Pt5), 1526-1531.
6. El-Awady, M.; Tabll, A.; Atef, K.; Yousef, S.; Omran, M.; El-Abd, Y.; Bader-Eldin, N.; Salem, A.; Zohny, S.; El-Garf, W. Antibody to E1 peptide of hepatitis C virus genotype 4 inhibits virus binding and entry to HepG2 cells in vitro. World J. Gastroenterol. 2006, 12 (16), 2530-2535.
7. El-Awady, M.; Tabll, A.; Redwan, E.; Youssef, S.; Omran, M.; Thakeb, F.; Demellawy, M. Flow cytometric detection of hepatitis C virus antigens in infected peripheral blood leukocytes: Binding and entry. World J. Gastroenterol 2005, 11 (33), 5203-5208.
8. El-Awady, M.; Tabll, A.; El-Abd, Y.; Bahgat, M.; Shoeb, H.; Youssef, S. Bader El-Din, N.; Redwan, El-R.; El-Demellawy, M.; Omran, M.; El-Garf, W.; Goueli, S. HepG2 cells support viral replication and gene expression of hepatitis C virus genotype 4 in vitro. World J. Gastroenterol. 2006, 14 (12(30)), 4836-4842.
9. El-Awady, M.; El Abd, Y.; Shoeb, H.; Tabll, A.; Hosny, A.; El Shenawy, R.; Atef, K.; Bader El Din, N.; Bahgat, M. Circulating viral core and E1 antigen levels as supplemental markers for HCV Chronic hepatitis. Virol. J. 2006, 1 (3(1)), 67.
10. Kohler, G.; Milstein, C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 1975, 7 (5517), 495-497.
11. Laemmli, U. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227, 680-685.
12. Sy, T.; Jamal, M. Epidemiology of hepatitis C virus (HCV) infection. Int. J. Med. Sci. 2006, 3 (2), 41-46.
13. Tarr, A.; Owsianka, A.; Timms, J.; McClure, C.; Brown, R.; Hickling, T.; Pietschmann, T.; Bartenschlager, R.; Patel, A.H.; Ball, J.K. Characterization of the hepatitis C virus E2 epitope defined by the broadly neutralizing monoclonal antibody AP33. Hepatology 2006, 43 (3), 592-601.
14. Dreux, M.; Pietschmann, T.; Granier, C.; Voisset, C.; Ricard-Blum, S.; Mangeot, P.; Keck, Z.; Foung, S.; Vu-Dac, N.; Dubuisson, J.; Bartenschlager, R.; Lavillette, D. High density lipoprotein inhibits hepatitis C virus-neutralizing antibodies by stimulating cell entry via activation of the scavenger receptor BI. J. Biol. Chem. 2006, 281 (27), 18285-18295.
15. Eren, R.; Landstein, D.; Terkieltaub, D.; Nussbaum, O.; Zauberman, A.; Ben-Porath, J.; Gopher, J.; Buchnick, R.; Kovjazin, R.; Rosenthal-Galili, Z.; Aviel, S.; Ilan, E.; Shoshany, Y.; Neville, L.; Waisman, T.; Ben-Moshe, O.; Kischitsky, A.; Foung, S.; Keck, Z.; Pappo, O.; Eid, A.; Jurim, O.; Zamir, G.; Galun, E.; Dagan, S. Preclinical evaluation of two neutralizing human monoclonal antibodies against hepatitis C virus (HCV): a potential treatment to prevent HCV reinfection in liver transplant patients. J. Virol. 2006, 80 (6), 2654-2664.
16. Petit, M.; Jolivet-Reynaud, C.; Peronnet, E.; Michal, Y.; Trepo, C. Mapping of a conformational epitope shared between E1 and E2 on the serum-derived human hepatitis C virus envelope. J. Biol. Chem. 2003, 278 (45), 44385-44392.
17. Cagnon, L.; Wagaman, P.; Bartenschlager, R.; Pietschmann, T.; Gao, T.; Kneteman, N.; Tyrrell, D.; Bahl, C.; Niven, P.; Lee, S.; Simmen, K. Application of the trak-C HCV core assay for monitoring antiviral activity in HCV replication systems. J. Virol. Meth. 2004, 118 (1), 23-31.
18. Shi, H.; Xie, L.; Huang, D.Z.; He, L.X. Detection of HCV antigen in the serum by immunodotting 2006, 22 (3), 336-338. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi.
19. Attallah, A.; Ismail, H.; Tabll, A.; Shiha, G.; El-Dosoky, I. A novel antigen detection immunoassay for field diagnosis of hepatitis C virus infection. J. Immunoassay Immunochem. 2003, 24 (4), 395-407.
20. Leary, T.; Gutierrez, R.; Muerhoff, A.; Birkenmeyer, L.; Desai, S.; Dawson, G. A chemiluminescent, magnetic particle-based immunoassay for the detection of hepatitis C virus core antigen in human serum or plasma. J. Med. Virol. 2006, 78 (11), 1436-1440.
21. Xie, L.; Wu, X.; Huang, D.; Chen, H.; He, L.; Wang, J.; Han, D. Clinical application and analysis of hepatitis C virus NS3 antigen detection by ELISA in human serum. Chin. Med. J. (Engl.) 2007, 20, 120(4), 294-299.
22. Doskeland, S.; Berdal, B. Bacterial antigen detection in body fluids: methods for rapid antigen concentration and reduction of nonspecific reactions. J. Clin. Microbiol. 1980, 11 (3), 80-384.
23. De Jonge, N.; Fillie, Y.E.; Deelder, A. A simple and rapid treatment (trichloroacetic acid precipitation) of serum samples to prevent non-specific reactions in the immunoassay of a proteoglycan. J. Immunol. Meth. 1987, 99, 195-197.
24. Tanaka, E.; Kiyosawa, K.; Matsumoto, A.; Yanagihara, O.; Ohta, Y. Serum levels of hepatitis C virus core protein in patients with chronic hepatitis C treated with interferon alpha. Hepatology 1996, 23, 1330-1333.
25. Tanaka, E.; Ohue, C.; Aoyagi, K.; Yamaguchi, K.; Yagi, S.; Kiyosawa, K.; Alter, H. Evaluation of a new enzyme immunoassay for hepatitis C virus (HCV) core antigen with clinical sensitivity approximating that of genomic amplification of HCV-RNA. Hepatology 2000, 32 (2), 388-393.